YU46803A - Heterociklilalkil piperidin derivati, njihova priprema i njihovi farmaceutski oblici - Google Patents

Heterociklilalkil piperidin derivati, njihova priprema i njihovi farmaceutski oblici

Info

Publication number
YU46803A
YU46803A YU46803A YUP46803A YU46803A YU 46803 A YU46803 A YU 46803A YU 46803 A YU46803 A YU 46803A YU P46803 A YUP46803 A YU P46803A YU 46803 A YU46803 A YU 46803A
Authority
YU
Yugoslavia
Prior art keywords
piperidine derivatives
preparation
compositions containing
containing same
radical
Prior art date
Application number
YU46803A
Other languages
English (en)
Inventor
Eric Bacque
Jean-Christophe Carry
Youssef El-Ahmad
Michel Evers
Philippe Hubert
Jean-Luc Malleron
Serge Mignani
Guy Pantel
Michel Tabart
Fabrice Vivian
Original Assignee
Aventis Pharma S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma S.A. filed Critical Aventis Pharma S.A.
Publication of YU46803A publication Critical patent/YU46803A/sh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

Pronalazak se odnosi na heterocikloalkil piperidin derivate opšte formule (I), gde X1, X2, X3, X4, i X5 su >C-R'5 do >C-R'5 gde jedan ili više njih je N; R2 je COOH alkiloksikarbonil, cikloalkiloksikarbonil, CN, -CONRaRb ili R2 je CH2OH, alkil supstituisani -CH=CH-Rc; R3 je fenil, heterociklil, alk-R03; Y predstavlja >CH-Re ili difluormetilen, karbonil, hidroksiiminometilen, alkiloksiimonometilen, cikloalkiloksiiminometilen radikal, ili cikloalkilen-1,1 radikal; i n=o do 4 gde se podrazumeva da radikali ili fenil ili heterociklične grupe koje su gore spomenute opcionalno mogu biti zamenjene, u enantiomernim ili diastereoizomernim oblicima ili njihovim smešama, i/ili kao što može biti slučaj u njihovim sin ili anti formama ili njihovim smešama i njihovim solima.[The invention concerns heterocyclylalkyl piperidine derivatives of general formula (I), wherein X1, X2, X3, X4 and X5 are >C-R'1 to >C-R'5 or one at most represents N; R2 is COOH, alkyloxycarbonyl, cycloalkyloxycarbonyl, CN, -CONRaRb or R2 is CH2OH, alkyl substituted or R2 is -CF2-Rc, -C(CH3)2-Rc, -CO-Rc, -CHOH-Rc, -C(cycloalkyl)-Rc or -CH=CH-Rc; R3 is phenyl, heterocyclyl. alk-RГє3; Y represents >CH-Re or a difluoromethylene, carbonyl, hydroxyiminomethylene, alkyloxyiminomethylene, cycloalkyloxyiminomethylene radical, or a cycloalkylene-1,1 radical; and n = 0 to 4 provided that the radicals or phenyl or heterocyclyl portions mentioned above can optionally be substituted, in the enantiomeric or diastereoisomeric forms or mixtures thereof, and/or as the case may be in their syn or anti form or mixture thereof and their salts.
YU46803A 2000-11-15 2001-11-14 Heterociklilalkil piperidin derivati, njihova priprema i njihovi farmaceutski oblici YU46803A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0014738A FR2816618B1 (fr) 2000-11-15 2000-11-15 Derives heterocyclylalcoyl piperidine, leur preparation et les compositions qui les contiennent

Publications (1)

Publication Number Publication Date
YU46803A true YU46803A (sh) 2006-05-25

Family

ID=8856503

Family Applications (1)

Application Number Title Priority Date Filing Date
YU46803A YU46803A (sh) 2000-11-15 2001-11-14 Heterociklilalkil piperidin derivati, njihova priprema i njihovi farmaceutski oblici

Country Status (28)

Country Link
EP (2) EP1695964A1 (sh)
JP (1) JP2004514661A (sh)
KR (1) KR100849608B1 (sh)
CN (1) CN1483031A (sh)
AR (1) AR034006A1 (sh)
AT (1) ATE337311T1 (sh)
AU (2) AU1836502A (sh)
BG (1) BG107793A (sh)
BR (1) BR0115312A (sh)
CA (1) CA2429311A1 (sh)
CZ (1) CZ20031316A3 (sh)
DE (1) DE60122567T2 (sh)
DK (1) DK1337529T3 (sh)
EA (1) EA200300568A1 (sh)
EE (1) EE200300207A (sh)
ES (1) ES2271119T3 (sh)
FR (1) FR2816618B1 (sh)
HR (1) HRP20030379A2 (sh)
HU (1) HUP0303758A3 (sh)
IL (1) IL155841A0 (sh)
NO (2) NO20032187L (sh)
PL (1) PL363004A1 (sh)
PT (1) PT1337529E (sh)
SK (1) SK5822003A3 (sh)
TN (1) TNSN01160A1 (sh)
WO (1) WO2002040474A2 (sh)
YU (1) YU46803A (sh)
ZA (1) ZA200303794B (sh)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20030019621A (ko) 2000-07-26 2003-03-06 스미스클라인비이참피이엘시이 항균 활성을 갖는 아미노피페리딘 퀴놀린 및 그의아자이소스테릭 유사체
GB0101577D0 (en) 2001-01-22 2001-03-07 Smithkline Beecham Plc Compounds
GB0112834D0 (en) 2001-05-25 2001-07-18 Smithkline Beecham Plc Medicaments
GB0112836D0 (en) 2001-05-25 2001-07-18 Smithkline Beecham Plc Medicaments
GB0118238D0 (en) * 2001-07-26 2001-09-19 Smithkline Beecham Plc Medicaments
AR038240A1 (es) 2002-01-29 2005-01-05 Glaxo Group Ltd Compuesto de piperidina, uso del mismo para la fabricacion de un medicamento, composicion farmaceutica que lo comprende y procedimiento para su preparacion
JP4508650B2 (ja) 2002-01-29 2010-07-21 グラクソ グループ リミテッド アミノピペリジン化合物、当該化合物の製法および当該化合物を含有する医薬組成物
TW200406413A (en) 2002-06-26 2004-05-01 Glaxo Group Ltd Compounds
AR040336A1 (es) 2002-06-26 2005-03-30 Glaxo Group Ltd Compuesto de piperidina, uso del mismo para la fabricacion de un medicamento, composicion farmaceutica que lo comprende y procedimiento para preparar dicho compuesto
FR2842807A1 (fr) 2002-07-23 2004-01-30 Aventis Pharma Sa Derives de la quinolyl propyl piperidine, procede et intermediaires de preparation et compositions les renfermant
GB0217294D0 (en) * 2002-07-25 2002-09-04 Glaxo Group Ltd Medicaments
FR2844270B1 (fr) 2002-09-11 2006-05-19 Aventis Pharma Sa Derives de la quinolyl propyl piperidine, leur procede et intermediaires de preparation et les compositions qui les contiennent
FR2844268B1 (fr) * 2002-09-11 2004-10-22 Aventis Pharma Sa Derives de la quinolyl propyl piperidine, leurs procedes et intermediaires de preparation et les compositions qui les contiennent
DE10256405A1 (de) * 2002-12-02 2004-06-17 Morphochem Aktiengesellschaft für kombinatorische Chemie Neue Verbindungen, die Topoisomerase IV inhibieren
JP4704755B2 (ja) 2002-11-05 2011-06-22 グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー 抗菌剤
ES2312839T3 (es) 2002-12-04 2009-03-01 Glaxo Group Limited Quinolinas y sus derivados nitrogenados y su uso como agentes antibacterianos.
US7232833B2 (en) 2003-03-28 2007-06-19 Novexel 4-substituted quinoline derivatives, method and intermediates for their preparation and pharmaceutical compositions containing them
FR2852954B1 (fr) * 2003-03-28 2006-07-14 Aventis Pharma Sa Derives de quinoleines-4-substituees, leurs procede et intermediaires de preparation et les compositions pharmaceutiques qui les contiennent
FR2862301B1 (fr) * 2003-11-17 2007-12-21 Aventis Pharma Sa Nouveau procede de preparation de quinoleines 3-fluorees
FR2867472B1 (fr) * 2004-03-12 2008-07-18 Aventis Pharma Sa Derives de quinoleines-4-substituees, leurs procede et intermediaires de preparation et les compositions pharmaceutiques qui les contiennent
US7709472B2 (en) 2005-01-25 2010-05-04 Glaxo Group Limited Antibacterial agents
WO2006081264A1 (en) 2005-01-25 2006-08-03 Glaxo Group Limited Antibacterial agents
EP1846418A4 (en) 2005-01-25 2009-12-23 Glaxo Group Ltd ANTIBACTERIAL ACTIVE SUBSTANCES
EP1846416A4 (en) 2005-01-25 2009-07-01 Glaxo Group Ltd ANTIBACTERIAL AGENTS
JP2008531709A (ja) 2005-03-01 2008-08-14 ワイス シンノリン化合物および肝臓x受容体調節物質としてのそれらの使用
MY150958A (en) 2005-06-16 2014-03-31 Astrazeneca Ab Compounds for the treatment of multi-drug resistant bacterial infections
CA2635126A1 (en) 2006-01-26 2007-08-02 Actelion Pharmaceuticals Ltd Tetrahydropyrane antibiotics
WO2007115947A1 (en) 2006-04-06 2007-10-18 Glaxo Group Limited Pyrrolo-quinoxalinone derivatives as antibacterials
EP1992628A1 (en) 2007-05-18 2008-11-19 Glaxo Group Limited Derivatives and analogs of N-ethylquinolones and N-ethylazaquinolones
MX2009013254A (es) 2007-06-15 2010-01-25 Actelion Pharmaceuticals Ltd Derivados 3-amino-6(1-amino-etil)-tetrahidropirano.
EP2080761A1 (en) 2008-01-18 2009-07-22 Glaxo Group Limited Compounds
US20110275661A1 (en) 2008-10-17 2011-11-10 Glaxo Group Limited Tricyclic nitrogen compounds used as antibacterials
US8318940B2 (en) 2009-01-15 2012-11-27 Glaxo Group Limited Naphthyridin-2 (1 H)-one compounds useful as antibacterials
US9273001B2 (en) * 2012-08-15 2016-03-01 Glaxo Group Limited Chemical process
MX2017002321A (es) 2014-08-22 2017-08-02 Glaxosmithkline Ip Dev Ltd Compuestos que contienen nitrogeno triciclico para tratar infeccion por neisseria gonorrhoeae.
WO2016138988A1 (en) * 2015-03-02 2016-09-09 University Of Copenhagen Piperazine inhibitors of bacterial gyrase and topoisomerase iv
UY36851A (es) 2015-08-16 2017-03-31 Glaxosmithkline Ip Dev Ltd Compuestos para uso en aplicaciones antibacterianas

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7908031A (nl) 1979-11-01 1981-06-01 Acf Chemiefarma Nv Nieuwe chinolinederivaten en farmaceutische preparaten die een dergelijke verbinding bevatten, alsmede werk- wijze voor het bereiden van deze verbindingen.
JPH0239546A (ja) 1988-07-29 1990-02-08 Origin Electric Co Ltd 混成集積回路の製造方法
NZ232091A (en) 1989-01-16 1990-12-21 Bellon Labor Sa Roger 7-fluoro-8-(piperazin-1-yl)-4-oxo-1,4-dihydro-benzo(b)(1,8)naphthyridine-3-carboxylic acid derivatives, preparation and pharmaceutical compositions thereof
WO1999037635A1 (en) * 1998-01-26 1999-07-29 Smithkline Beecham Plc Quinoline derivatives as antibacterials
EP1144404A1 (en) * 1999-01-20 2001-10-17 Smithkline Beecham Plc Piperidinylquinolines as protein tyrosine kinase inhibitors
FR2852954B1 (fr) * 2003-03-28 2006-07-14 Aventis Pharma Sa Derives de quinoleines-4-substituees, leurs procede et intermediaires de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
CA2429311A1 (en) 2002-05-23
ES2271119T3 (es) 2007-04-16
BG107793A (bg) 2004-08-31
DE60122567T2 (de) 2007-08-23
TNSN01160A1 (fr) 2005-11-10
NO20032187D0 (no) 2003-05-14
KR20030060934A (ko) 2003-07-16
CN1483031A (zh) 2004-03-17
AU2002218365B2 (en) 2007-07-05
NO20032187L (no) 2003-06-26
WO2002040474A3 (fr) 2002-10-31
ATE337311T1 (de) 2006-09-15
EA200300568A1 (ru) 2003-12-25
BR0115312A (pt) 2003-09-23
JP2004514661A (ja) 2004-05-20
HRP20030379A2 (en) 2005-04-30
HUP0303758A2 (hu) 2004-03-01
DE60122567D1 (de) 2006-10-05
AU1836502A (en) 2002-05-27
WO2002040474A2 (fr) 2002-05-23
IL155841A0 (en) 2003-12-23
SK5822003A3 (en) 2004-06-08
EP1337529B1 (fr) 2006-08-23
ZA200303794B (en) 2004-06-29
EP1695964A1 (fr) 2006-08-30
EE200300207A (et) 2003-08-15
FR2816618A1 (fr) 2002-05-17
KR100849608B1 (ko) 2008-07-31
DK1337529T3 (da) 2006-12-18
NO20072142L (no) 2007-04-25
FR2816618B1 (fr) 2002-12-27
HUP0303758A3 (en) 2009-08-28
EP1337529A2 (fr) 2003-08-27
PT1337529E (pt) 2006-12-29
CZ20031316A3 (cs) 2003-10-15
AR034006A1 (es) 2004-01-21
PL363004A1 (en) 2004-11-15

Similar Documents

Publication Publication Date Title
YU46803A (sh) Heterociklilalkil piperidin derivati, njihova priprema i njihovi farmaceutski oblici
WO2003082798A8 (es) Compuestos naturales y derivados de éstos para la prevención y el tratamiento de enfermedades cardiovasculares, hepáticas, renales y para aplicaciones cosméticas
AP9701039A0 (en) Derivatives of 2- (2-oxo-ethlidene)-imidazolidin-4-one.
ATE334666T1 (de) Neue fettsäureanaloge zur behandlung der fettleber
GR75353B (sh)
BG104998A (en) Isothiazole derivatives useful as anticancer agents
MXPA04006322A (es) Derivados de 6-fluorobiciclo[3.1.0]hexano.
CA2113229A1 (en) Anti-fibrotic quinazolinone-containing compositions and methods for the use thereof
IS8448A (is) Lifrarbólgu C-veirutálmar
ATE270817T1 (de) Fungizide
NZ514711A (en) Compounds useful as anti-inflammatory agents
ATE270103T1 (de) Aminophenoxyessigsäure derivate als neuroschützende mittel
HK1040985A1 (en) Cell adhesion-inibiting antiinflammatory and immunesuppressive compounds.
AU2003228674A1 (en) Muscarinic antagonists
SE9802974D0 (sv) New crystalline forms
ATE171188T1 (de) In 15-stellung substituierte 4-azasteroide
MX9604483A (es) Derivados de benzamida, composiciones que contienen dicho derivado y uso de las mismas.
IL136359A (en) Dihydrobenzofuran substituted phthalazin-1-one derivatives and pharmaceutical compositions containing the same
BG105919A (en) Erythromycin derivatives
HK1068332A1 (en) Pyrane derivatives as both ace-and nep-inhibitors
BG100884A (en) Benzamide derivative, compositions containing said derivative and use thereof
WO2003013456A3 (en) Personal care compositions
GR3017348T3 (en) Novel isoindolinone derivative, preparation thereof, and pharmaceutical compositions containing same.
WO2000071538A3 (en) 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives
TW235294B (sh)